IPhO News

The role of the Medical Science Liaison is one of the more coveted job opportunities for clinical pharmacists within the pharmaceutical industry. This role provides clinical pharmacists with the opportunity to engage in highly scientific and cutting-edge discussions on patient-specific drug therapy and disease states with leading healthcare professionals (HCPs) in both the academic and community-based settings. In addition to the clinical aspects, the MSL role requires the individual to think strategically about territory planning and coverage to ensure that field-based activities and individual contributions align with overall company objectives.

In this installment of our "Ask the Advisors" column, we asked some of our prestigious advisory board members “Why Do Pharmacists Make the Most Valuable Industry Employees?"

To see what they said, read below and then "join the conversation" by sharing your own views on this subject!

The IPhO Advocacy tour made its most recent stop at Novartis Headquarters in East Hanover, NJ this week. If you would like to work with IPhO staff to organize a similar visit to your company or your favorite school of pharmacy, please contact us!

100 Novartis pharmacists joined the conversation to learn more about IPhO and its mission to advance the careers of industry pharmacists by promoting our indispensable value. From the front of the room, looking out on all that talent reminded me of the bright future we have and how much we can accomplish by working together!

The IPhO Advocacy Committee has begun the rollout of its comprehensive plan to promote the value of industry pharmacists. Our efforts will be reaching i) Industry employers , ii) Pharmacy School Administration and Faculty, and iii) Students and Fellows, among others.

We are kicking off a new column, "Ask the Advisors," to relay advice from our very experienced and prestigious advisory board members. Each column will feature responses to a single critical question put to our board. For our inaugural column we asked our advisors to briefly describe the single most impactful professional development course or seminar that they have taken. And here is what they said.

In theory, a recent decision by the Second Circuit Court of Appeals may change the way that pharmaceutical manufacturers promote their products. The court sided with a sales representative’s right to free speech when communicating with physicians. This result has raised some very interesting questions about FDA’s regulation of “off-label” information.

Madison, NJ - October 8, 2012

Announcing the launch of the Industry Pharmacists Organization (IPhO), the first and only professional pharmacy organization dedicated exclusively to advancing the careers of pharmaceutical industry-based pharmacists. The organization was founded by experienced industry pharmacists with the determined purpose of benefiting industry pharmacists everywhere.

As a career industry pharmacist, and on behalf of our organization and the IPhO advisory board, I am excited to introduce to you the first and only professional pharmacy organization dedicated specifically to the professional needs of pharmaceutical industry-based pharmacists!

If you are one of the first 500 pharmacists to join IPhO as a full member, not only will you be designated as a Founding 500 IPhO Member, you will also be supporting pharmacy student scholarships! Now and every year you continue your annual membership, you will be part of IPhO's commitment to support the professional development and education of future industry pharmacists.

Beginning NOW, if you are one of the first 500 eligible** pharmacists to join IPhO as a member, you will become a Founding 500 IPhO Member! We invite our Founding 500 level members to play an important role in shaping the present and future focus of our organization. We will consistently seek and incorporate feedback from our Founding 500 members to help us ensure that IPhO is meeting the needs, wants and concerns of members like you.